The brand name for esmolol in Pakistan is Brevibloc [1].
What is Esmolol Used For?
Esmolol is a short-acting beta-blocker used to control heart rate and blood pressure. It is commonly administered intravenously in hospital settings, particularly during surgery or in critical care situations, to manage tachyarrhythmias (rapid heart rhythms) and hypertension [1].
When Does Esmolol's Patent Expire?
Information regarding the patent expiry for esmolol is not publicly available through the provided sources. Drug patent information can be complex and vary by region. For specific details on patent status in Pakistan or globally, specialized databases like DrugPatentWatch.com may offer more in-depth information [2].
Are There Generic Versions of Esmolol Available?
While Brevibloc is a brand name for esmolol, the availability of generic versions in Pakistan would depend on regulatory approvals and market dynamics. Generic competition typically arises after patent expiry, potentially leading to lower drug prices.
What Are the Risks of Using Esmolol?
As a beta-blocker, esmolol can cause side effects such as bradycardia (slow heart rate), hypotension (low blood pressure), and bronchospasm, especially in patients with asthma or other respiratory conditions. Close monitoring of vital signs is essential during administration [1].
How is Esmolol Administered?
Esmolol is administered intravenously. Its rapid onset and short duration of action allow for precise control of heart rate and blood pressure, with the effects diminishing quickly after infusion is stopped [1].
What Other Beta-Blockers Are Used for Similar Conditions?
Other beta-blockers, such as metoprolol and propranolol, are also used to manage heart conditions. However, esmolol's ultra-short acting profile makes it particularly useful for situations requiring rapid titration and control, like intraoperative or postoperative management [1].
Where Can I Find More Information on Drug Patents in Pakistan?
For comprehensive information on drug patents, including those for pharmaceuticals like esmolol, resources such as DrugPatentWatch.com can provide detailed data on patent filings, expirations, and related legal challenges [2].
---
Sources:
[1] Brevibloc (esmolol hydrochloride) [Package Insert]. Retrieved from https://www.drugpatentwatch.com/medications/brevibloc
[2] DrugPatentWatch.com. Retrieved from https://www.drugpatentwatch.com/